• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素在多发性硬化症的治疗方面前景光明。

Curcumin has bright prospects for the treatment of multiple sclerosis.

机构信息

Division for Radiation Safety and Immune Tolerance, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo, Japan.

出版信息

Int Immunopharmacol. 2011 Mar;11(3):323-30. doi: 10.1016/j.intimp.2010.08.013. Epub 2010 Sep 8.

DOI:10.1016/j.intimp.2010.08.013
PMID:20828641
Abstract

Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system (CNS). It is associated with a variety of pathophysiological features, including breakdown of the blood-brain barrier (BBB), autoimmune attack, injury of axons and myelin sheaths. Th17 cells are considered as a key immunological player for the pathophysiological process of MS. Neuroprotective approaches work best prior to the initiation of damage, suggesting that some safe and effective prophylaxis would be highly desirable. Curcumin, a dietary spice from turmeric, has outstanding anti-inflammation and neuroprotective effects. Herein, we review key features of curcumin involved biology, pharmacology, and medicinal chemistry and discuss its potential relevance to pathophysiological progress of MS.

摘要

多发性硬化症(MS)是一种中枢神经系统(CNS)的慢性炎症性自身免疫性疾病。它与多种病理生理特征有关,包括血脑屏障(BBB)的破坏、自身免疫攻击、轴突和髓鞘的损伤。Th17 细胞被认为是 MS 病理生理过程的关键免疫参与者。神经保护方法在损伤发生之前效果最佳,这表明需要高度理想的一些安全有效的预防措施。姜黄素是一种来自姜黄的膳食香料,具有出色的抗炎和神经保护作用。本文综述了姜黄素涉及生物学、药理学和药物化学的关键特征,并讨论了其与 MS 病理生理进展的潜在相关性。

相似文献

1
Curcumin has bright prospects for the treatment of multiple sclerosis.姜黄素在多发性硬化症的治疗方面前景光明。
Int Immunopharmacol. 2011 Mar;11(3):323-30. doi: 10.1016/j.intimp.2010.08.013. Epub 2010 Sep 8.
2
Pathophysiology of inflammation and tissue injury in multiple sclerosis: what are the targets for therapy.多发性硬化症炎症和组织损伤的病理生理学:治疗的靶点是什么。
J Neurol Sci. 2011 Jul 15;306(1-2):167-9. doi: 10.1016/j.jns.2010.07.023. Epub 2010 Aug 16.
3
Curcumin as a therapeutic candidate for multiple sclerosis: Molecular mechanisms and targets.姜黄素作为多发性硬化症的治疗候选药物:分子机制和靶点。
J Cell Physiol. 2019 Aug;234(8):12237-12248. doi: 10.1002/jcp.27965. Epub 2018 Dec 10.
4
Therapeutic potential of curcumin for multiple sclerosis.姜黄素治疗多发性硬化症的潜力。
Neurol Sci. 2018 Feb;39(2):207-214. doi: 10.1007/s10072-017-3149-5. Epub 2017 Oct 27.
5
The pathology of multiple sclerosis.多发性硬化症的病理学
Neurol Clin. 1995 Feb;13(1):1-21.
6
Hormonal influences in multiple sclerosis: new therapeutic benefits for steroids.多发性硬化症中的激素影响:类固醇的新治疗益处。
Maturitas. 2011 Jan;68(1):47-51. doi: 10.1016/j.maturitas.2010.09.014. Epub 2010 Oct 29.
7
Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.姜黄素在慢性病中作用的药理学基础:一种具有现代靶点的古老香料。
Trends Pharmacol Sci. 2009 Feb;30(2):85-94. doi: 10.1016/j.tips.2008.11.002. Epub 2008 Dec 26.
8
Immunology of multiple sclerosis.多发性硬化症的免疫学
Clin Neurosci. 1994;2(3-4):229-45.
9
[Experimental methods in the treatment of multiple sclerosis--new possibilities and hopes].
Przegl Lek. 2005;62(2):115-8.
10
Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects.姜黄素的多种抗抑郁作用机制:抗炎、单胺能、抗氧化、免疫调节和神经保护作用的综述。
J Psychopharmacol. 2012 Dec;26(12):1512-24. doi: 10.1177/0269881112458732. Epub 2012 Oct 3.

引用本文的文献

1
SIRT7 ameliorates Th17/Treg imbalance by desuccinylation of STAT3 to improve immune thrombocytopenia.SIRT7通过使信号转导和转录激活因子3(STAT3)去琥珀酰化来改善Th17/调节性T细胞(Treg)失衡,从而改善免疫性血小板减少症。
Clin Transl Immunology. 2025 Jul 15;14(7):e70048. doi: 10.1002/cti2.70048. eCollection 2025.
2
Potential Application of Plant-Derived Compounds in Multiple Sclerosis Management.植物源化合物在多发性硬化症治疗中的潜在应用。
Nutrients. 2024 Sep 5;16(17):2996. doi: 10.3390/nu16172996.
3
The Use of Traditional and Complementary Medicine Among Patients With Multiple Sclerosis in Morocco.
摩洛哥多发性硬化症患者对传统医学和补充医学的使用情况。
Int J MS Care. 2024 Jun 5;26(Q3):140-143. doi: 10.7224/1537-2073.2022-116. eCollection 2024 May.
4
The ameliorative effects of curcumin nanomicelle on testicular damage in the mouse model of multiple sclerosis.姜黄素纳米胶束对多发性硬化症小鼠模型睾丸损伤的改善作用。
BMC Complement Med Ther. 2024 May 22;24(1):200. doi: 10.1186/s12906-024-04423-3.
5
Immunoregulatory Effects of the Active Form of Vitamin D (Calcitriol), Individually and in Combination with Curcumin, on Peripheral Blood Mononuclear Cells (PBMCs) of Multiple Sclerosis (MS) Patients.活性维生素 D(骨化三醇)单独及与姜黄素联合对多发性硬化症(MS)患者外周血单个核细胞(PBMC)的免疫调节作用。
Antiinflamm Antiallergy Agents Med Chem. 2024;23(2):138-147. doi: 10.2174/0118715230293847240314073359.
6
Curcumin as a regulator of Th17 cells: Unveiling the mechanisms.姜黄素作为Th17细胞的调节剂:揭示其机制
Food Chem (Oxf). 2024 Mar 12;8:100198. doi: 10.1016/j.fochms.2024.100198. eCollection 2024 Jul 30.
7
Curcumin, inflammation, and neurological disorders: How are they linked?姜黄素、炎症与神经疾病:它们是如何关联的?
Integr Med Res. 2023 Sep;12(3):100968. doi: 10.1016/j.imr.2023.100968. Epub 2023 Jun 25.
8
Curcumin's spice-infused therapeutic promise: disease severity alleviation in a mouse model of multiple sclerosis via modulation of immune responses.姜黄素的香料注入治疗潜力:通过调节免疫反应减轻多发性硬化症小鼠模型中的疾病严重程度。
Mol Biol Rep. 2023 Nov;50(11):8843-8853. doi: 10.1007/s11033-023-08781-y. Epub 2023 Sep 3.
9
Research progress on the mechanism of curcumin in cerebral ischemia/reperfusion injury: a narrative review.姜黄素在脑缺血/再灌注损伤中的作用机制研究进展:叙述性综述。
Apoptosis. 2023 Oct;28(9-10):1285-1303. doi: 10.1007/s10495-023-01869-7. Epub 2023 Jun 26.
10
Therapeutic Implications of Some Natural Products for Neuroimmune Diseases: A Narrative of Clinical Studies Review.一些天然产物对神经免疫疾病的治疗意义:临床研究综述
Evid Based Complement Alternat Med. 2023 Apr 13;2023:5583996. doi: 10.1155/2023/5583996. eCollection 2023.